Targeted Radiopharmaceuticals Summit US 2024

Join World Courier at the 3rd Annual Targeted Radiopharmaceutical Summit US, the leading event dedicated to radio-conjugates this year. Explore strategies for novel targets, optimize radioisotope supply chains, and delve into combination and personalized therapies to stay ahead in the competitive TRP landscape.

This summit brings together key players from pharma and biotech like Novartis, Bayer, AstraZeneca, Perspective Therapeutics, Telix Therapeutics, ARTBIO, OranoMed, and more. From early discovery to clinical stages and supply chain management, join us for a comprehensive overview of radiopharmaceutical advancements.

With a focus on meeting both business and scientific needs, this year introduces new tracks for early and late-stage clinical development along with enhanced networking opportunities for business development professionals.